프로그램

11:00~11:50 등록
11:50~12:00 개회사 김영태(대한폐암학회이사장)
12:00~12:40 Luncheon Symposium 한국다케다제약 좌장: 안명주(성균관의대)
12:00~12:40 The evolving treatment landscape in ALK+NSCLC : the emerging role of brigatinib 이대호(울산의대)
12:40~13:00 Coffee Break
Session I. Biomarkers and Companion Diagnostics in Lung Cancer 좌장: 이창훈(부산의대)
13:00~13:30 Targeted Agents in Lung Cancer 최윤라(성균관의대)
13:30~14:00 Immuno-Oncology Agents in Lung Cancer 강은주(고려의대)
14:00~14:20 Coffee Break
Session II. Joint symposium with KOSRO 좌장: 인광호(고려의대), 안성자(전남의대)
14:20~14:40 Radiotherapy for patients with underlying lung disease 김학재 (서울의대)
14:40~15:00 Management of radiation pneumonitis 정병호(성균관의대)
15:00~15:20 Emerging role of radiotherapy in stage IV lung cancer 서양권 (국립암센터)
15:20~15:40 Coffee Break
Session III. Interactive session 좌장: 이호석(부산의대)
15:40~16:15 Case Discussion (I) : Practical approach to the patient with suspicious pleural metastasis 양희철 (국립암센터)
패널: 김태정(성균관의대), 하직환(가톨릭의대)
16:15~16:50 Case Discussion (II) : Practical approach to the patient with malignant pleural effusion 하직환(가톨릭의대)
패널: 김태정(성균관의대), 양희철(국립암센터)
16:50~17:10 Coffee Break
Session IV. N2 nodes-positive Non-small Cell Lung Cancer 좌장: 김영철(전남의대)
17:10~17:30 Role for surgery in N2 nodes-positive lung cancer 김진국(성균관의대)
17:30~17:50 Systemic treatment for N2 non-small cell lung cancer 김영생(가천의대)
17:50~18:05 숙제보고 지원준(울산의대)
18:05~18:15 학술상-학술연구비 시상
18:15~ 만찬